BRUSSELS, BELGIUM / RankWire.AI / – The European Commission has finalized an agreement to acquire €2.1 million worth of PCR tests to address the ongoing Bundibugyo Ebola outbreak. These open-platform diagnostics will enhance detection capabilities and bolster laboratory infrastructure amid the crisis. The procurement process was supported by the European Health and Digital Executive Agency. Shipments are set to commence in August, providing essential diagnostic tools as health authorities deal with increasing case numbers in the Democratic Republic of the Congo.
The PCR testing kits will be sent to the World Health Organization’s Logistics Hub for Global Health Emergencies in Dubai. WHO will oversee their distribution to the regions involved in the Ebola response. PCR testing is vital for accurate case confirmation because laboratories can process large volumes of samples efficiently and precisely. This equipment integrates seamlessly with existing laboratory setups, enabling quicker diagnosis. Rapid confirmation allows health teams to identify infected individuals, provide appropriate care and isolation, and conduct effective contact tracing around confirmed cases.
This latest procurement complements a separate European Commission initiative, which allocated €2.5 million for rapid molecular point-of-care tests and testing equipment. These supplies aim to support the Africa Centres for Disease Control and Prevention. Collectively, the two agreements raise the European Union’s diagnostic support investment to €4.6 million. These measures are part of the broader European effort to respond to the Bundibugyo virus emergency, which has increasingly strained healthcare systems in affected regions of Central and East Africa.
Expansion of diagnostic efforts as outbreak intensifies
By August 12, WHO reported a total of 4,665 confirmed Ebola cases and 2,184 deaths in the Democratic Republic of the Congo. The outbreak affected 54 health zones across six provinces, including Ituri, North Kivu, South Kivu, Haut-Uélé, Tshopo, and Bas-Uélé. WHO characterized the situation as the largest Ebola outbreak ever documented in the country. The agency also highlighted the persistent and intense transmission, with interconnected geographic clusters contributing to ongoing spread within the affected areas.
On August 14, WHO maintained its highest national risk level for the Democratic Republic of the Congo. It classified the risk to neighboring nations as high, while the threat to other countries remained low. After its second meeting, WHO issued updated temporary guidance on August 24, focusing on surveillance, case detection, infection prevention, clinical treatment, community engagement, and measures related to domestic mobility and mass gatherings.
European aid efforts now total €493 million
The European Commission announced a mobilization of €493 million designated for emergency aid, vaccines, treatments, and health security initiatives across the Great Lakes and Uganda regions. European health authorities have actively supported surveillance efforts, laboratory operations, and preparedness activities during the outbreak. The European Centre for Disease Prevention and Control continues to assess the risk to European populations as very low, citing the necessity of direct contact with infectious bodily fluids and the low likelihood of sustained transmission within Europe.
The Bundibugyo Ebola outbreak remains classified as a public health emergency of international concern, a designation given by WHO on May 17. Unlike the more commonly reported Zaire ebolavirus, the Bundibugyo virus currently lacks an approved vaccine or specific treatment. WHO emphasizes ongoing surveillance, rapid diagnosis, patient isolation, clinical management, infection control, and contact monitoring as essential response strategies. The latest PCR procurement by the European Commission enhances laboratory capacity to support these efforts, with WHO and Africa CDC coordinating health operations with national authorities in affected and neighboring regions.